AU2008903349A0 - Treatment of eye diseases and excessive neovascularization using combined therapy - Google Patents

Treatment of eye diseases and excessive neovascularization using combined therapy

Info

Publication number
AU2008903349A0
AU2008903349A0 AU2008903349A AU2008903349A AU2008903349A0 AU 2008903349 A0 AU2008903349 A0 AU 2008903349A0 AU 2008903349 A AU2008903349 A AU 2008903349A AU 2008903349 A AU2008903349 A AU 2008903349A AU 2008903349 A0 AU2008903349 A0 AU 2008903349A0
Authority
AU
Australia
Prior art keywords
treatment
eye diseases
combined therapy
excessive neovascularization
neovascularization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008903349A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angioblast Systems Inc
Original Assignee
Angioblast Systems Inc
Filing date
Publication date
Application filed by Angioblast Systems Inc filed Critical Angioblast Systems Inc
Publication of AU2008903349A0 publication Critical patent/AU2008903349A0/en
Priority to EP09794792A priority Critical patent/EP2294184A4/en
Priority to KR1020117002350A priority patent/KR20110036101A/en
Priority to CN2009801249790A priority patent/CN102076844B/en
Priority to PCT/US2009/003902 priority patent/WO2010005527A1/en
Priority to SG10201510586PA priority patent/SG10201510586PA/en
Priority to CA2729303A priority patent/CA2729303A1/en
Priority to AU2009269149A priority patent/AU2009269149B2/en
Priority to JP2011516339A priority patent/JP2011526892A/en
Priority to US13/002,229 priority patent/US20110200612A1/en
Priority to JP2014138345A priority patent/JP2015038059A/en
Priority to AU2016203973A priority patent/AU2016203973A1/en
Abandoned legal-status Critical Current

Links

AU2008903349A 2008-06-30 2008-06-30 Treatment of eye diseases and excessive neovascularization using combined therapy Abandoned AU2008903349A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US13/002,229 US20110200612A1 (en) 2008-06-30 2009-06-29 Treatment of eye diseases and excessive neovascularization using combined therapy
SG10201510586PA SG10201510586PA (en) 2008-06-30 2009-06-29 Treatment of Eye Diseases And Excessive Neovascularization Using A Combined Therapy
KR1020117002350A KR20110036101A (en) 2008-06-30 2009-06-29 Treatment of eye diseases and excessive neovascularization using a combined therapy
CN2009801249790A CN102076844B (en) 2008-06-30 2009-06-29 Treatment of eye diseases and excessive neovascularization using a combined therapy
PCT/US2009/003902 WO2010005527A1 (en) 2008-06-30 2009-06-29 Treatment of eye diseases and excessive neovascularization using a combined therapy
EP09794792A EP2294184A4 (en) 2008-06-30 2009-06-29 Treatment of eye diseases and excessive neovascularization using a combined therapy
CA2729303A CA2729303A1 (en) 2008-06-30 2009-06-29 Treatment of eye diseases and excessive neovascularization using a combined therapy
AU2009269149A AU2009269149B2 (en) 2008-06-30 2009-06-29 Treatment of eye diseases and excessive neovascularization using a combined therapy
JP2011516339A JP2011526892A (en) 2008-06-30 2009-06-29 Treatment of ocular diseases and hypervascularization using combination therapy
JP2014138345A JP2015038059A (en) 2008-06-30 2014-07-04 Treatment of eye diseases and excessive neovascularization using combined therapy
AU2016203973A AU2016203973A1 (en) 2008-06-30 2016-06-14 Treatment of eye diseases and excessive neovascularization using combined therapy

Publications (1)

Publication Number Publication Date
AU2008903349A0 true AU2008903349A0 (en) 2008-07-17

Family

ID=

Similar Documents

Publication Publication Date Title
SG10201510586PA (en) Treatment of Eye Diseases And Excessive Neovascularization Using A Combined Therapy
IL242268A0 (en) Combinations and modes of administration of therapeutic agents and combination therapy
HK1201046A1 (en) Methods of treating ophthalmic diseases
IL229786A (en) Use of inhibitors for preparation of medicaments for treating ocular edema, neovascularization and related diseases
ZA201106268B (en) Toll-like receptor modulators and treatment of diseases
EP2097107A4 (en) Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
EP2493475A4 (en) Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
ZA201106730B (en) Methods of treatment using combination therapy
ZA200906165B (en) Treatment and prevention of neurodegenerative diseases using gene therapy
HK1129600A1 (en) Treatment of excessive neovascularization
WO2009023311A9 (en) Transcutaneous delivery of therapeutic agents
PT2056863T (en) Treatment of ocular diseases
WO2011071995A9 (en) Compounds and methods of treating ocular disorders
SI2148667T1 (en) Use of cyclohexanehexol derivatives in the treatment of ocular diseases
EP2624821A4 (en) Combination therapy for the treatment of depression and other non-infectious diseases
IL213703A0 (en) Compounds and methods for the treatment of pain and other diseases
EP2106260B8 (en) Insulin sensitisers and methods of treatment
AU2008903349A0 (en) Treatment of eye diseases and excessive neovascularization using combined therapy
GB201108289D0 (en) Therapeutic garment and method of providing therapy using the same
AU2007900995A0 (en) Therapeutic Compositions and Methods of Treatment
GB0801511D0 (en) The treatment of ophthalmic diseases
AU2008900544A0 (en) Prevention and treatment of certain diseases using novel dietary anti-cytokine therapy
GB0700755D0 (en) The Treatment of ophthalmic diseases
ZA200906883B (en) Methods of treating ophthalmic diseases
GB0901727D0 (en) The treatment of ophthalmic diseases